Suppr超能文献

经皮机械性粥样血栓切除术与动脉搭桥手术治疗股腘动脉支架内再狭窄的预算影响分析

Percutaneous mechanical atherothrombectomy versus arterial bypass surgery for femoropopliteal in-stent restenosis: a budget impact analysis.

作者信息

Stanberry Benedict, Maclean Drew, Elbasty Ahmed

机构信息

Institute of Healthcare Leadership and Management, Oxford, United Kingdom.

Department of Interventional Radiology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

出版信息

J Soc Cardiovasc Angiogr Interv. 2025 Jun 17;4(6):103616. doi: 10.1016/j.jscai.2025.103616. eCollection 2025 Jun.

Abstract

BACKGROUND

There is a growing body of evidence attesting to the safety and efficacy of percutaneous mechanical atherothrombectomy (PMA) for patients with femoropopliteal (FP) in-stent restenosis (ISR) and occlusion. This study aimed to compare the costs of PMA with those of arterial bypass surgery and analyze the potential impact the introduction of PMA could have on the budget of a typical vascular service.

METHODS

A budget impact model with a 5-year time horizon was developed assuming an annual caseload of 12 patients with FP-ISR for whom arterial bypass surgery was the only intervention available for treating FP-ISR before the introduction of a PMA device (Rotarex; BD) and that, after its introduction, 50% of patients would be treated by this endovascular approach. Interviews with local clinical experts were used to map these 2 treatment pathways in detail, and all other inputs were sourced from national registries and published literature. All costs were based on 2022 pound sterling. Uncertainty in the model was explored through one-way sensitivity analysis and through 2 alternative scenarios that investigated the impact of different FP-ISR incidence rates, intervention mixes, and postsurgery lengths of stay.

RESULTS

The analysis estimated that the introduction of PMA into future practice at a typical vascular service could achieve a cost saving of £4750 for each patient with FP-ISR undergoing an endovascular procedure instead of bypass surgery. This became a total budget impact of £142,497 over the model's 5-year time horizon. Reductions in postsurgery lengths of stay, delayed discharges, and operating theater utilization were the major drivers of cost savings.

CONCLUSIONS

The introduction of PMA as a treatment option for FP-ISR can deliver significant cost savings for vascular services due to substantial reductions in inpatient bed and operating theater use that are maintained across sensitivity and scenario analysis. It has a valuable role to play in improving day surgery rates and reducing the intensity of vascular surgery workloads.

摘要

背景

越来越多的证据证明,经皮机械性粥样血栓切除术(PMA)对于股腘(FP)支架内再狭窄(ISR)和闭塞患者具有安全性和有效性。本研究旨在比较PMA与动脉搭桥手术的成本,并分析引入PMA可能对典型血管服务预算产生的潜在影响。

方法

建立了一个为期5年的预算影响模型,假设每年有12例FP-ISR患者,在引入PMA设备(Rotarex;BD)之前,动脉搭桥手术是治疗FP-ISR的唯一可用干预措施,引入后,50%的患者将接受这种血管内治疗方法。通过与当地临床专家访谈详细描绘这两种治疗途径,所有其他输入数据均来自国家登记处和已发表的文献。所有成本均以2022年英镑为基础。通过单向敏感性分析以及研究不同FP-ISR发病率、干预组合和术后住院时间影响的两种替代方案,探讨模型中的不确定性。

结果

分析估计,在典型血管服务中将PMA引入未来实践,对于每例接受血管内手术而非搭桥手术的FP-ISR患者可节省4750英镑成本。在模型的5年时间范围内,这带来的总预算影响为142,497英镑。术后住院时间、延迟出院和手术室利用率的降低是成本节省的主要驱动因素。

结论

引入PMA作为FP-ISR的一种治疗选择,可显著节省血管服务成本,原因是住院床位和手术室使用大幅减少,且在敏感性分析和情景分析中均保持这一趋势。它在提高日间手术率和减轻血管手术工作量强度方面具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a2/12230475/5828f6ab031e/gr2.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验